SIM
VRX

Sonora Investment Management’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History

Sonora Investment Management’s Portfolio VRX Stock Details VRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-360
Closed -$8K – 1307
2018
Q2 		$8K Hold
360
– – ﹤0.01% 900
2018
Q1 		$5.73K Hold
360
– – ﹤0.01% 919
2017
Q4 		$7.48K Buy
360
+300
+500% +$6.23K ﹤0.01% 885
2017
Q3 		$860 Hold
60
– – ﹤0.01% 1082
2017
Q2 		$1.04K Hold
60
– – ﹤0.01% 933
2017
Q1 		$662 Hold
60
– – ﹤0.01% 896
2016
Q4 		$871 Hold
60
– – ﹤0.01% 810
2016
Q3 		$1.47K Hold
60
– – ﹤0.01% 768
2016
Q2 		$1.21K Hold
60
– – ﹤0.01% 800
2016
Q1 		$2.11K Hold
60
– – ﹤0.01% 824
2015
Q4 		$6K Sell
60
-46
-43% -$4.6K ﹤0.01% 618
2015
Q3 		$24K Buy
+106
New +$24K 0.01% 311

Sonora Investment Management's VRX Position: Q3 2018 in Review

Sonora Investment Management sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q3 2018, closing a stake of 360 shares — an estimated $8K sold.

Sonora Investment Management first reported a position in VRX in Q3 2015 and held it in 12 quarters. The position peaked at $24K in Q3 2015. 0 funds tracked by Wall St. Rank hold VRX as of Q3 2018.

  • Sonora Investment Management reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q3 2018 after selling out during the quarter.
  • Sonora Investment Management sold 360 VALEANT PHARMACEUTICALS INTL shares in Q3 2018, an estimated $8K.
  • Sonora Investment Management first reported a position in VALEANT PHARMACEUTICALS INTL in Q3 2015 and held it in 12 quarters.
  • Sonora Investment Management's VALEANT PHARMACEUTICALS INTL position peaked at $24K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q3 2018.

Based on Sonora Investment Management's 13F filing for Q3 2018, filed 18 Oct 2018.